Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33096134.
- Also identified by DOI 10.1016/j.jaad.2020.10.023 and PMC identifier 8046713.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There are no well-defined clinical factors to predict the risk of occult invasion in melanoma of the lentigo maligna type (LM) before complete histopathologic analysis. To evaluate whether clinical size was a predictor of invasion in LM and subclinical extension. Consecutive cases of LM were recorded in a prospectively maintained database from 2006 to 2019. Patient and tumor data were recorded during initial evaluation. The LM clinical area was calculated in square millimeters (length × width). All patients were treated with staged excision. We included 600 patients. The mean age was 65.9 years (standard deviation, 12.3; range, 27-95 years); 62.8% (n = 377) were men. The mean LM clinical area was 128.32 mm<sup>2</sup> for in situ lesions versus 200.14 mm for invasive lesions (P = .1). Based on quantile regression, the median margin required for complete removal increased with LM clinical area. The study was performed in a tertiary cancer center with possible referral bias and more complex cases. LM can present with variable clinical size, which may correlate with subclinical extension; however, the presence of invasion is not well estimated by LM clinical area.
Medical subject headings
- Hutchinson's Melanotic Freckle
- Mohs Surgery
- Skin Neoplasms